Osama Salloum

Dr. Osama Salloum


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
Dan Cristian ManescuDan Cristian Manescu
Dan Cristian Manescu
Cristina CasalsCristina Casals
Cristina Casals
Anna Kurkiewicz-PiotrowskaAnna Kurkiewicz-Piotrowska
Anna Kurkiewicz-Piotrowska
TCTayana Silva de Carvalho
Tayana Silva de Carvalho
CPCostin Petcu
Costin Petcu
RARăzvan Alexandrescu
Răzvan Alexandrescu
Nutraceuticals are evaluated as though efficacy were a stable ingredient property, although net value may vary with exercise stimulus, exposure schedule, recovery pressure, athlete state, and prioritized outcome. This structured narrative review integrates exercise-adaptation biology, periodized sports nutrition, training-load and recovery models, precision nutrition, and human evidence for sport-relevant interventions. Searches of PubMed/MEDLINE, Web of Science, and Scopus were updated through August 2026 and supplemented by citation tracking. General efficacy was separated from direct evidence of timing, context, or state modification. Nutraceutical Periodization for eXercise (NPX) is an allocation layer applied only after safety, legality, product quality, and plausible efficacy are established. It defines four non-sequential functional windows—performance exploitation, adaptation-permissive signaling, restoration, and resilience—and separates intervention strategy, training context, athlete state, and outcome hierarchy. Four falsifiable propositions test context modification, temporal allocation, bottleneck/state dependence, and whole-policy utility. None of the allocation claims in the present evidence map met the criterion for direct NPX allocation evidence. NPX therefore formalizes hypothetical allocation rules rather than an established supplementation policy; proposed improvements in athlete-centered outcomes or equivalent outcomes with less exposure, burden, or harm remain to be prospectively tested against an explicitly defined active evidence-based comparator. Interaction and policy trials are needed to establish the value and boundaries of these rules.

20 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Dan Cristian ManescuDan Cristian Manescu
Dan Cristian Manescu
Cristina CasalsCristina Casals
Cristina Casals
Anna Kurkiewicz-PiotrowskaAnna Kurkiewicz-Piotrowska
Anna Kurkiewicz-Piotrowska
TCTayana Silva de Carvalho
Tayana Silva de Carvalho
CPCostin Petcu
Costin Petcu
RARăzvan Alexandrescu
Răzvan Alexandrescu
Nutraceuticals are evaluated as though efficacy were a stable ingredient property, although net value may vary with exercise stimulus, exposure schedule, recovery pressure, athlete state, and prioritized outcome. This structured narrative review integrates exercise-adaptation biology, pe-riodized sports nutrition, training-load and recovery models, precision nutrition, and human evi-dence for sport-relevant interventions. Searches of PubMed/MEDLINE, Web of Science, and Scopus were updated through August 2026 and supplemented by citation tracking. General efficacy was separated from direct evidence of timing, context, or state modification. Nutraceutical Periodiza-tion for eXercise (NPX) is an allocation layer applied only after safety, legality, product quality, and plausible efficacy are established. It defines four non-sequential functional win-dows—performance exploitation, adaptation-permissive signaling, restoration, and resili-ence—and separates intervention strategy, training context, athlete state, and outcome hierarchy. Four falsifiable propositions test context modification, temporal allocation, bottleneck/state de-pendence, and whole-policy utility. Despite limited direct evidence for most allocation rules, NPX converts compound-specific efficacy into prospectively testable decisions. Targeted allocation may improve athlete-centered outcomes or preserve them with fewer exposures, lower burden, or less harm than standardized evidence-based use. Prospective interaction and policy trials are needed to establish the value and boundaries of these rules.